Quality Talks with Gabriella Adlovits, The RAQS Manager

28/08/2020

The following interview is part of the Omixon interview series that we are conducting with Key Opinion Leaders at Omixon. The next interviewee is the leader of Omixon’s RAQSM team, Gabriella Adlovits, Head of Regulatory Affairs and Quality Systems Management, who talks about her experiences and the role of...

ASHI Regional Education Workshop, August 21 & 28, 2020

27/08/2020

🧬ASHI Regional Workshop will be a VIRTUAL MEETING!🧬 As corporate sponsor, on behalf of Omixon, Michael Mignogno (Sales Manager, The Americas-Omixon) will hold a 10-min Talk + 5-min Q&A at 3.45PM on Friday, 28th August, 2020. Read more about the program and register HERE. We hope to...

Webinar – COVID-19 and HLA: The Current State of Knowledge and Future Directions

12/08/2020

The SARS-CoV-2 pandemic has become one of the most serious public health issues. The adaptive immune system has a fundamental role in the recognition and destruction of the virus. Join us for a webinar with Máté Manczinger (Project Leader at Csaba Pál Laboratory, Biological Research Centre, Szeged, Hungary)...

Webinar em Português – Atualizações do HLA Twin v4.2 e Análise de Dados de Amostras Difíceis

09/07/2020

Junte-se a nós para um webinar com Gustavo Milson (Technical Sales Specialist) e Renata Santos (Senior Field Application Scientist). Neste webinar, queremos proporcionar informações das atualizações da nova versão do HLA Twin v4.2, e uma introdução de como revisar amostras no software. Vamos revisar a análise de amostra...

Should the best mismatched donor be chosen based on KIR typing? KIR role in transplantation and implications

29/06/2020

Written by Vera Siffnerová (FAS, Omixon) A choice of the most suitable donor for each transplant patient has always been the main focus and challenge for the whole team that is involved in the selection process. There is a high number of criteria that are evaluated, different approaches and...